Evidence map›Paper›PMID 26337785›Full record

ArticleMalaria journal2015

Implementation and application of a multiplex assay to detect malaria-specific antibodies: a promising tool for assessing malaria transmission in Southeast Asian pre-elimination areas.

Karen Kerkhof, Lydie Canier, Saorin Kim, Somony Heng, Tho Sochantha, Siv Sovannaroth, Inès Vigan-Womas, Marc Coosemans, Vincent Sluydts, Didier Ménard and 1 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. eLife · 2021
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Using Serological Markers for the Surveillance ofPathogens (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Spatial, environmental, and individual associations withFrontiers in cellular and infection microbiology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 5 countries.

Karen KerkhofDepartment of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium. kkerkhof@itg.be.
Lydie CanierMolecular Epidemiology Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia. lydie.canier@gmail.com.
Saorin KimMolecular Epidemiology Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia. ksaorin@pasteur-kh.org.
Somony HengNational Centre for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia. hengsomony@gmail.com.
Tho SochanthaNational Centre for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia. thosochantha@gmail.com.
Siv SovannarothNational Centre for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia. sivsovannaroths@gmail.com.
Inès Vigan-WomasInfectious Diseases Immunology, Institut Pasteur de Madagascar, Antananarivo, Madagascar. ines@pasteur.mg.
Marc CoosemansDepartment of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium. mcoosemans@itg.be.
Vincent SluydtsDepartment of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium. vsluydts@itg.be.
Didier MénardMolecular Epidemiology Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia. dmenard@pasteur-kh.org.
Lies DurnezDepartment of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium. ldurnez@itg.be.
Cambodia National Malaria Center · KHInstitut Pasteur du Cambodge · KHUniversity of Antwerp · BEInstitute of Biomedical Science · GBInstitut Pasteur de Madagascar · MG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEpidemiological surveillance is a key activity in malaria control and elimination in low-transmission and pre-elimination settings. Hence, sensitive tools for estimating malaria force of infection are crucial. Serological markers might provide additional information in estimating force of infection in low-endemic areas along with classical parasite detection methods. Serological markers can be used to estimate recent, past or present malaria exposure, depending on the used markers and their half-life.

methodsAn assay based on 14 Plasmodium-specific peptides, one peptide specific for Anopheles gambiae saliva protein and five Plasmodium-specific recombinant proteins was developed for the MAGPIX system, assessed for its performance, and applied on blood spots from 2000 individuals collected in the Ratanakiri Province, Cambodia.

resultsA significant correlation for the use of 1000 and 2000 beads/antigen/well as well as for the monoplex versus multiplex assay was observed for all antigens (p < 0.05). For the majority of antigens, antigen-coupled beads were stable for at least 2 months. The assay was very reproducible with limited intercoupling, interplate and intraplate variability (mean RSD <15 %). Estimating seroconversion and seroreversion per antigen using reversible catalytic models and models allowing two seroconversion rates showed higher seroconversion rates in adults.

conclusionThe multiplex bead-based immunoassay was successfully implemented and analysis of field blood samples shows that changes detected in force of malaria infection vary according to the serological markers used. Multivariate analysis of the antibody responses and insights into the half-life of antibodies are crucial for improving the interpretation of these results and for identifying the most useful serological markers of past and recent malaria infection.

Indexed as

AdolescentAdultAgedAged, 80 and overAntibodies, ProtozoanCambodiaChildChild, PreschoolHumansImmunoassayInfantMalaria, FalciparumMalaria, VivaxMiddle AgedParasitologyPlasmodium falciparumAntibodies, Protozoan

Identifiers

PMID26337785
PMCPMC4558921
OpenAlexW2135185486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.